Abstract
Background: Merosin-deficient congenital muscular dystrophy (CMD) is characterized clinically by hypotonia and muscular weakness and, on imaging studies, by white matter (WM) abnormality. Objective: To evaluate MRI findings in Brazilian patients with merosin-deficient CMD. Materials and methods: Twenty-five patients were evaluated using MRI. Three patients presented with partial merosin deficiency and 22 with total merosin deficiency. Follow-up examinations were done in 7 cases. T1- and T2-weighted images were performed in all examinations, and fluid-attenuated inversion recovery (FLAIR) was performed in 15. Enhanced images were done in 11 cases. The WM involvement was classified according to location and severity. Results: From 1991 to 2004, 32 MRI examinations were performed. Severe involvement was found in 23 patients in the frontal and temporal lobes, in 18 patients in the parietal lobes, and in 7 patients in the occipital lobes. The brain stem (n=5), cerebellum (n=6), internal capsules (n=1), and external capsules (n=5) were also affected. One patient had occipital pachygyria, and one had cerebellar vermian hypoplasia. No gadolinium enhancement was noted. Follow-up MRI showed no interval change (n=4), progression (n=1), or improvement of the findings (n=2). Conclusion: This series of patients demonstrated that there was no correlation between the extent of WM abnormality on MRI and the clinical status and degree of merosin deficiency (partial or total). Bilateral WM involvement was seen to be more prominent in the parietal, frontal, and temporal regions of the brain. The brain stem and internal and external capsules were less affected. Cerebellar WM involvement is rare. Changes on follow-up imaging studies did not correlate with the clinical status of the patient.
Similar content being viewed by others
References
Muntoni F, Valero de Bernabe B, Bittner R, et al (2003) 114th ENMC International Workshop on Congenital Muscular Dystrophy (CMD). Eighth Workshop of the International Consortium on CMD; Third Workshop of the MYO-CLUSTER project GENRE, 17–19 January 2003, Naarden, The Netherlands. Neuromuscul Disord 13:579–588
Tomé FM (1999) The Peter Emil Becker Award lecture 1998. The saga of congenital muscular dystrophy. Neuropediatrics 30:55–65
Muntoni F, Brockington M, Blake DJ, et al. (2002) Defective glycosylation in muscular dystrophy. Lancet 360:1419–1421
Muntoni F, Bertini E, Bonnemann C, et al (2002) The 98th ENMC International Workshop on Congenital Muscular Dystrophy (CMD), Seventh Workshop of the International Consortium on CMD, Second Workshop of the MYO-CLUSTER project GENRE, 26–28 October, 2001, Naarden, The Netherlands. Neuromuscul Disord 12:889–896
Muntoni F, Guicheney P (2002) The 85th ENMC International Workshop on Congenital Muscular Dystrophy. The Sixth International CMD Workshop. The First Workshop of the MYO-CLUSTER project GENRE, 27–28 October, 2001, Naarden, The Netherlands. Neuromuscul Disord 12:69–78
Villanova M, Malandrini A, Sabatelli P, et al (1997) Localization of laminin α 2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study. Acta Neuropathol (Berl) 94:567–571
Villanova M, Malandrini A, Toti P, et al (1996) Localization of merosin in the normal human brain: implications for congenital muscular dystrophy with merosin deficiency. J Submicrosc Cytol Pathol 28:1–4
Farina L, Morandi L, Milanesi I, et al (1998) Congenital muscular dystrophy with merosin deficiency: MRI findings in five patients. Neuroradiology 40:807–811
Glihuis HJ, ten Donkelaar HJ, Tanke RB, et al (2002) Nonmuscular involvement in merosin-negative congenital muscular dystrophy. Pediatr Neurol 26:30–36
Lamer S, Carlier R-Y, Pinard J-M, et al (1998) Congenital muscular dystrophy: use of brain MR imaging findings to predict merosin deficiency. Radiology 206:811–816
Tomé FM, Evangelista T, Leclerc A, et al (1994) Congenital muscular dystrophy with merosin deficiency. CR Acad Sci Paris 317:351–357
Caro PA, Scavina M, Hoffman E, et al (1999) MR imaging findings in children with merosin-deficient congenital muscular dystrophy. AJNR 20:324–326
Arahat K, Ishii H, Hayashi YK (1995) Congenital muscular dystrophies. Curr Opin Neurol 8:385–390
Hebling-Leclerc A, Zhang X, Topaloglu H, et al (1995) Mutations in the laminin α-2 chain gene (LAMA 2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 11:216–218
Miyagoe-Suzuki Y, Nakagawa M, Takeda S (2000) Merosin and congenital muscular dystrophy. Microsc Res Tech 48:181–91
Philpot J, Cowan F, Pennock J, et al (1999) Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul Disord 9:81–85
Tsao C-Y, Mendell JR, Rusin J, et al (1998) Congenital muscular dystrophy with complete laminin-α-2-deficiency, cortical dysplasia and cerebral white matter changes in children. J Child Neurol 13:253–256
Sunada Y, Edgar TS, Lotz BP, et al (1995) Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 45:2084–2089
Pini A, Merlini L, Tomé FMS, et al. (1996) Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia. Report of three Italian cases in two families. Brain Dev 18:316–322
Mercuri E, Gruter-Andrew J, Philpot J, et al (1999) Cognitive abilities in children with congenital muscular dystrophy: correlation with brain MRI and merosin status. Neuromuscul Disord 9:383–387
Reed UC, Marie SK, Vainzof M, et al (1996) Congenital muscular dystrophy with cerebral white matter hypodensity. Correlation of clinical features and merosin deficiency. Brain Dev 18:53–58
van der Knaap MS, Smit LME, Barth PG, et al (1997) Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 42:50–59
Philpot J, Topaloglu H, Pennock J, et al (1995) Familial concordance of brain magnetic resonance imaging changes in congenital muscular dystrophy. Neuromuscul Disord 5:227–231
Herrmann R, Straub V, Meyer K, et al (1996) Congenital muscular dystrophy with laminin α 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry. Eur J Pediatr 155:968–976
Barkovich AJ (1998) Neuroimaging manifestations and classification of congenital muscular dystrophies. AJNR 19:1389–1396
Trevisan CP, Martinello F, Ferruzza E, et al (1996) Brain alterations in the classical form of congenital muscular dystrophy. Clinical and neuroimaging follow-up of 12 cases: a correlation with the expression of merosin in muscle. Childs Nerv Syst 12:604–610
Taratuto AL, Lubieniecki F, Diaz D, et al (1999) Merosin-deficient congenital muscular dystrophy associated with abnormal cerebral cortical gyration: an autopsy study. Neuromuscul Disord 9:86–94
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leite, C.C., Lucato, L.T., Martin, M.G.M. et al. Merosin-deficient congenital muscular dystrophy (CMD): a study of 25 Brazilian patients using MRI. Pediatr Radiol 35, 572–579 (2005). https://doi.org/10.1007/s00247-004-1398-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-004-1398-y